October 02, 2023
Vyera Pharmaceuticals, a drug company tied to convicted fraudster Martin Shkreli, received bankruptcy court approval Monday in Delaware for its plan of liquidation after reaching consensus with its stakeholders.
September 14, 2023
Bankrupt drug developer Vyera Pharmaceuticals LLC told a Delaware judge Thursday that it had reached consensus on an updated Chapter 11 plan that resolves opposition to the proposal through the addition of a new rights offering in the reorganized company.
September 13, 2023
A bankrupt pharmaceutical company tied to convicted securities fraudster Martin Shkreli received court approval Wednesday for a $650,000 sale of its parasite-treating Daraprim assets, but confirmation of its Chapter 11 plan was delayed until Thursday.